FMP

FMP

Enter

JNCE - Jounce Therapeu...

photo-url-https://financialmodelingprep.com/image-stock/JNCE.png

Jounce Therapeutics, Inc.

JNCE

NASDAQ

Inactive Equity

Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid tumors. It is also developing JTX-8064, an antibody that binds to leukocyte immunoglobulin like receptor B2, which is a cell surface receptor expressed on macrophages; JTX -1484 for myeloid; and JTX-1811, an anti-CCR8 monoclonal antibody designed to selectively deplete intra-tumoral T regulatory cells in the tumor microenvironment. Jounce Therapeutics, Inc. was incorporated in 2012 and is headquartered in Cambridge, Massachusetts.

1.88 USD

0 (0%)

About

ceo

Ms. Kimberlee Cobleigh Drapkin C.P.A., CPA

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid tumors. It is also developing JTX-8064, an antibody that binds to leukocyte immunoglobulin like receptor B2, which is a cell surface receptor expressed on macrophages; JTX -1484 for myeloid; and JTX-1811, an anti-CCR8 monoclonal antibody designed to selectively deplete intra-tumoral T regulatory cells in the tumor microenvironment. Jounce Therapeutics...

CIK

0001640455

ISIN

US4811161011

CUSIP

481116101

Address

780 Memorial Drive

Phone

857 259 3840

Country

US

Employee

141

IPO Date

Jan 26, 2017

JNCE Financial Summary

CIK

0001640455

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

481116101

ISIN

US4811161011

Country

US

Price

1.88

Beta

0.75

Volume Avg.

3.47M

Market Cap

98.95M

Shares

-

52-Week

0.5773-5.37

DCF

2.92

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-1.96

P/B

-

Website

https://jouncetx.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest JNCE News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep